Influence of protein transduction domains on target-specific chimeric proteins

被引:16
作者
Bachran, C [1 ]
Heisler, I [1 ]
Fuchs, H [1 ]
Sutherland, M [1 ]
机构
[1] Univ Med Berlin, Charite, Inst Klin Chem & Pathobiochem, D-12200 Berlin, Germany
关键词
cell penetrating peptides; cellular uptake; drug delivery; endocytosis; Trojan peptides; drug targeting;
D O I
10.1016/j.bbrc.2005.09.095
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Direct targeting to the cytoplasm and nucleus using protein transduction domains (PTD) has been described to be efficient but non-cell-type-specific, and only has clinical relevance when the molecule is active exclusively in the diseased cell. The use of PTDs is an attractive mechanism to improve drug delivery. In this work, we designed recombinant proteins that contain epidermal growth factor as ligand to render uptake target cell-specific. We evaluated the potential of several PTDs to induce the cytosolic uptake of the catalytic domain of diphtheria toxin by measuring cytotoxicity. Although PTD-dependent membrane transfer is very low, the proteins exhibited concentration-dependent cytotoxic activity. Higher binding at 4 degrees C compared to 37 degrees C suggests that uptake by the PTDs MTS and TLM occurs via an endocytic pathway. Non-specific binding is predominantly a function of the PTD and greatly increases by substitution of a non-polar glycine with a negatively charged glutamate in the PTD HA2. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:602 / 609
页数:8
相关论文
共 46 条
[1]
TUMOR-CELL RETENTION OF ANTIBODY FAB FRAGMENTS IS ENHANCED BY AN ATTACHED HIV TAT PROTEIN-DERIVED PEPTIDE [J].
ANDERSON, DC ;
NICHOLS, E ;
MANGER, R ;
WOODLE, D ;
BARRY, M ;
FRITZBERG, AR .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 194 (02) :876-884
[2]
Peptide-derivatized shell-cross-linked nanoparticles. 2. Biocompatibility evaluation [J].
Becker, ML ;
Bailey, LO ;
Wooley, KL .
BIOCONJUGATE CHEMISTRY, 2004, 15 (04) :710-717
[3]
Beerens A. M. J., 2003, Current Gene Therapy, V3, P486, DOI 10.2174/1566523034578258
[4]
Tat peptide-mediated cellular delivery:: back to basics [J].
Brooks, H ;
Lebleu, B ;
Vivès, E .
ADVANCED DRUG DELIVERY REVIEWS, 2005, 57 (04) :559-577
[5]
DEROSSI D, 1994, J BIOL CHEM, V269, P10444
[6]
Studies on the internalization mechanism of cationic cell-penetrating peptides [J].
Drin, G ;
Cottin, S ;
Blanc, E ;
Rees, AR ;
Temsamani, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (33) :31192-31201
[7]
Protein transduction domain of HIV-1 Tat protein promotes efficient delivery of DNA into mammalian cells [J].
Eguchi, A ;
Akuta, T ;
Okuyama, H ;
Senda, T ;
Yokoi, H ;
Inokuchi, H ;
Fujita, S ;
Hayakawa, T ;
Takeda, K ;
Hasegawa, M ;
Nakanishi, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (28) :26204-26210
[8]
Intercellular trafficking and protein delivery by a herpesvirus structural protein [J].
Elliott, G ;
OHare, P .
CELL, 1997, 88 (02) :223-233
[9]
Ability of the Tat basic domain and VP22 to mediate cell binding, but not membrane translocation of the diphtheria toxin A-fragment [J].
Falnes, PO ;
Wesche, J ;
Olsnes, S .
BIOCHEMISTRY, 2001, 40 (14) :4349-4358
[10]
CELLULAR UPTAKE OF THE TAT PROTEIN FROM HUMAN IMMUNODEFICIENCY VIRUS [J].
FRANKEL, AD ;
PABO, CO .
CELL, 1988, 55 (06) :1189-1193